Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Reexamination Certificate
2008-01-29
2008-01-29
Naff, David M. (Department: 1657)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
C435S180000, C435S181000, C435S188000, C435S191000
Reexamination Certificate
active
10757843
ABSTRACT:
The present invention is directed to arginine deiminase modified with polyethylene glycol, to methods of treating cancer, and to methods of treating and/or inhibiting metastasis.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4609546 (1986-09-01), Hiratani
patent: 5372942 (1994-12-01), McGarrity et al.
patent: 5447722 (1995-09-01), Lang et al.
patent: 5468478 (1995-11-01), Saifer et al.
patent: 5474928 (1995-12-01), Takaku et al.
patent: 5804183 (1998-09-01), Filpula et al.
patent: 5916793 (1999-06-01), Filpula et al.
patent: 6132713 (2000-10-01), Fiipula et al.
patent: 0 230 777 (1987-08-01), None
patent: 0 372 752 (1990-06-01), None
patent: 0 414 007 (1991-02-01), None
patent: 0 442 724 (1991-08-01), None
patent: 0 897 011 (1999-02-01), None
patent: 53490 (1990-02-01), None
patent: 4 121 187 (1992-04-01), None
patent: 3 209 338 (2001-09-01), None
patent: WO 94/05332 (1994-03-01), None
patent: WO 96/34015 (1996-10-01), None
patent: WO 98/33519 (1998-08-01), None
patent: WO 98/51784 (1998-11-01), None
Abuchowski, A. et al., “Effect of Covalent Attachment of Polyethylene Glycol on Immunogenicity and Circulating Life of Bovine Liver Catalase”,J. Biol. Chem., 1977, 252(11), 3582-3586.
Abuchowski, A., et al., “Treatment of L5178Y Tumor-Bearing BDF Mice with a Nonimmunogenic-Asparaginase”,Cancer Terat. Rep., 1979, 63(6), 1127-1132.
Gill, P. et al., “Inhibition of Cell Division in L5178Y Cells by Arginine-Degrading Mycoplasmas: The Frole of Arginine Deiminase”,Can. J. Microbiol., 1970, 16, 415-419.
Habeeb, A.F.S.A., “Determination of Free Amino Groups in Proteins by Trinitrobenezenesulfonic Acid”,Analyt. Biochem., 1966, 14, 328-336.
Hershfield, M.S. et al., “Treatment of Adenosine Deaminase”,New Engl. J. Medicine, 1987, 316(10), 589-596.
Jeffe, N. et al., “Favorable Remission Induction Rate with Twice Weekely Doses of 1-Asparaginase”,Cancer Res., 1973, 33(1), 1-4.
Jones, J.B., “The Effect of Arginine Deiminase on Murine Leukemic Lymphoblasts”,Ph.D. Dissertation, The University of Oklahoma, 1981, 1-165.
Kamisaki, et al., “Increased Antitumor Activity of Escherichia Coli 1-Asparaginase by Modification with Monomethoxypolyethylene Glycol”,Gann, 1982, 73-470-474.
Kamisaki, et al., “Reduction in Immunogenicity and Clearance Frate ofEscherichia Coli1-Asparaginase by Modification with Monomethoxypolyethylene Glycol”,J. Pharmacol. Exp. Ther., 1981, 216(2), 410-414.
Kidd, J.G. “Aspariginase and Cancer-Yesterday and Today”,Cancer Res., 1970, 33, 1-14.
Kondo, K. et al., “Cloning and Sequence Analysis of the Arginine Deiminase Gene from Mycoplasma Arginini”,Mol. Gen. Genet., 1990, 221, 81-86.
Misawa, S. et al., “High -Level Expression of Mycoplasma Arginine Deiminase inEscherichia coliand Its Efficient Renaturation as an Anti-Tumor Enzyme”,J. Biotechnology, 1994, 36, 145-155.
Miyazaki, K. et al., “Potent Growth Inhibition of Human Tumor Cells in Culture by Aginine Deiminase Purified from a Culture Medium of a Mycoplasma-Infected Cell Line”,Cancer Res., 1990, 50,4522-4527.
Monfardini, C. et al., “A Branched Monomethoxypoly(Ethylene Glycol) for Protein Modification”,Bioconj. Chem., 1995, 6, 62-69.
Naio, M. et al., “Alteration of the Substrate Specificity ofAspergillus oryzaeβ-Galactosidase by Modification with Polyethylene Glycol”,J. Appl. Biochem., 1984, 6, 91-102.
Oginsky, “[92] Isolation and Determination of Arginine and Citrulline”,Meth. Enzymol., 1957, 3, 639-642.
Ohno, T. et al., “Cloning and Nucleotide Sequence of the Gene Encoding Arginine Deiminase of Mycoplasma Arginini”,Infect. Immun., 1990, 58, 3788-3795.
Park, Y.K. et al., “Pharmacology ofEscherichia coli-L-Asparaginase Polyethylene Glycol Adduct”,Anticancer Res., 1981, 1, 373-376.
Pyatak, P.S. et al., “Preparation of a Polyethylene Glycol: Superoxide Dismutase Adduct and an Examination of its Blood Circulating Life and Anti-Inflammatory Activity”,Res. Commun. Chem. Path. Pharmacol., 1980, 29(1), 113-127.
Sayers, J.R. et al., “Rapid High-Efficiency Site Directed Mutagenesis by the Phosphorothioate Approach”,Biotechniques, 1992, 13(4), 592-596.
Stocks, S.J. et al., “A Flurometric Assay of the Degree of Modification of Protein Primary Armines with Polyethylene Glycol”,Analyt. Biochem., 1986, 154, 232-234.
Su, T. et al., “Cloning of cDNA for Argininosuccinate Synthetase mRNA and Study of Enzyme Overproduction in a Human Cell Line”,J. Biol. Chem., 1981, 256(22), 11826-11831.
Sugimura, K. et al., “High Sensitivity of Human Melanoma Cell Lines to the Growth Inhibitory Activity of Mycoplasmal Arginine Deiminase in Vitro”,Melanoma Res., 1992, 2, 191-196.
Sugimura, K. et al., “Identification and Purification of Arginine Deiminase that Originated from Mycoplasma Arginini”,Infect Immun., 1990, 58*8, 2510-2515.
Takaku, H. et al., “Anti-tumor Activity of Arginine Deiminase from Mycoplasma Arginini and its Growth-Inhibitory Mechanism”,Int. J. Cancer, 1995, 86, 840-846.
Takaku, H. et al., “Chemical Modification by Polyethylene Glycol of the Anti-Tumor Enzyme Arginine Deiminase from Mycoplasma Arginini”,Jpn. J. Cancer Res., 1993, 84, 1195-1200.
Takaku, H. et al., “In Vivo Anti-Tumor Activity of Arginine Deiminase Purified From Mycoplasma Arginini”,Int. J. Cancer, 1992, 51, 244-249.
Teske, E. et al., “Polyethylene Glycol-L-Aspariginase Versus Native L-Asparaginase in Canine Non-Hodgkin's Lymphoma”,Eur. J. Cancer, 1990, 26(8), 891-895.
Zalipsky, et al., “Use of Functionalized Poly(Ethylene Glycol)s for Modification of Polypeptides”,Polyethylene Glycol Chem., Biotechnical and Biomedical Applns., 1992, 21, 347-370.
Misawa, S. et al., “High-Level Expression ofMycoplasmaArginine Deiminase inEscherichia coliand its Efficient Renaturation as an Anti-Tumor Enzyme”,J. Biotechnology, 1994, 36, 145-155.
van Wagtendonk, et al., “Nitrogen metabolism in protozoa”,Comparative Biochemistry of Nitrogen Metabolism(J.W. Campbell ed.), 1970, 1-56.
Chang, et al. “Arginase modulates nitric oxide production in activated macrophages”,Am. J. Physiol: Heart and Circul. Physiol., 1998, 274, H342-H348.
McDonald, et al., “A Caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the Arginine paradox”,J. Biol. Chem., 1997, 272, 31213-31216.
Deckers, P.J, et al. “The effect of tumor size on concomitant tumor immunity”,Cancer Res., 1973, 33(1), 33-39.
Fenske, J.D., et al., “Role of arginine deiminase in growth ofMycoplasma hominus”, J. Bacteriol., 1976, 126, 501-510.
Lang, K. et al., “Catalysis of protein folding by prolyl isomerase”,Nature, 1987, 329, 268-270.
Craig, S. et al., “Single amino acid mutations block a late step in the folding og B-Lactamase fromStaphylococcus aureus”, J. Mol. Biol., 1985, 185, 681-687.
Joppich, et al., “Peptides flanked by two polymer chains, 1-synthesis of Glycl-L-tryptophylglycine substituted by poly(ethylene oxide) at both the carboxy and the amino end groups”,Macromol. Chem., 1979, 180, 1381-1385.
Harasawa, R. et al., “Nucleotide Sequence of the Arginine Deiminase Gene ofMycoplasma hominis,” Microbiol. Immunol., 1992, 36(6), 661-665.
Takaku, H. et al., “Anti-tumor Activity of Arginine Deiminase fromMycoplasma argininiand Its Growth-inhibitory Mechanism,”Jpn. J. Cancer Res., Sep. 1995, 86(9), 840-846.
Fraser, C. et al., “Borrelia burgdorferi(section 69 of 70) of the complete genome”, Dec. 16, 1997, Database Accession No. AE001183, XP 002211866.
Knodler, Leigh A. et al., “Cloning and Expression of a Prokaryotic Enzyme, Arginine Deiminase., from a Primitive EukaryoteGiardia intestinalis”, Journa
Naff David M.
Polaris Group
Woodcock & Washburn LLP
LandOfFree
Method of treatment with modified arginine deiminase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment with modified arginine deiminase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment with modified arginine deiminase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3934408